XML 16 R4.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Operating expenses        
Research and development $ 10,867,983 $ 11,252,850 $ 32,793,835 $ 33,107,222
General and administrative 4,505,406 4,013,581 12,807,465 12,384,074
Amortization of intangible asset 7,317 7,317 21,950 21,950
Total operating expenses 15,380,706 15,273,748 45,623,250 45,513,246
Loss from operations (15,380,706) (15,273,748) (45,623,250) (45,513,246)
Other income (expense)        
Interest income 415,831 547,072 1,178,362 2,178,060
Other income, net 0 129,310 0 350,063
Net loss $ (14,964,875) $ (14,597,366) $ (44,444,888) $ (42,985,123)
Net loss per share attributable to common stockholders, basic (in dollars per share) $ (0.38) $ (0.49) $ (1.20) $ (1.45)
Net loss per share attributable to common stockholders, diluted (in dollars per share) $ (0.38) $ (0.49) $ (1.20) $ (1.45)
Weighted-average common shares outstanding, basic (in shares) 39,670,095 29,841,883 37,077,041 29,622,670
Weighted-average common shares outstanding, diluted (in shares) 39,670,095 29,841,883 37,077,041 29,622,670
Other comprehensive loss:        
Unrealized loss from marketable securities $ 0 $ 7,845 $ 0 $ 8,624
Comprehensive Loss $ (14,964,875) $ (14,589,521) $ (44,444,888) $ (42,976,499)